Citius Pharmaceuticals, Inc.

NasdaqCM:CTXR Stock Report

Mkt Cap: US$204.7m

Citius Pharmaceuticals Management

How experienced are the management team and are they aligned to shareholders interests?

2.5yrs

Average management tenure


CEO

Leonard Mazur (77 yo)

8.33yrs

Tenure

US$1,190,056

Compensation

Mr. Leonard L. Mazur has been Chief Executive Officer of Citius Pharmaceuticals, Inc. since May 01, 2022. He is a Director of Hillstream BioPharma Inc since July 2021. He has been Executive Chairman and Se...


CEO Compensation Analysis

How has Leonard Mazur's remuneration changed compared to Citius Pharmaceuticals's earnings?
DateTotal Comp.SalaryCompany Earnings
Sep 30 2022US$1mUS$400k

-US$34m

Jun 30 2022n/an/a

-US$31m

Mar 31 2022n/an/a

-US$29m

Dec 31 2021n/an/a

-US$26m

Sep 30 2021US$788kUS$348k

-US$25m

Jun 30 2021n/an/a

-US$24m

Mar 31 2021n/an/a

-US$21m

Dec 31 2020n/an/a

-US$21m

Sep 30 2020US$550kUS$250k

-US$18m

Jun 30 2020n/an/a

-US$17m

Mar 31 2020n/an/a

-US$17m

Dec 31 2019n/an/a

-US$16m

Sep 30 2019US$473kUS$250k

-US$16m

Jun 30 2019n/an/a

-US$15m

Mar 31 2019n/an/a

-US$12m

Dec 31 2018n/an/a

-US$13m

Sep 30 2018US$398kUS$250k

-US$13m

Jun 30 2018n/an/a

-US$13m

Mar 31 2018n/an/a

-US$13m

Dec 31 2017n/an/a

-US$11m

Sep 30 2017US$307kUS$250k

-US$10m

Jun 30 2017n/an/a

-US$10m

Mar 31 2017n/an/a

-US$11m

Dec 31 2016n/an/a

-US$9m

Sep 30 2016US$558kUS$250k

-US$8m

Compensation vs Market: Leonard's total compensation ($USD1.19M) is about average for companies of similar size in the US market ($USD1.65M).

Compensation vs Earnings: Leonard's compensation has increased whilst the company is unprofitable.


Leadership Team

NamePositionTenureCompensationOwnership
Leonard Mazur
Co-Founder6.83yrsUS$1.19m7.01%
$ 14.4m
Myron Holubiak
Co-Founder & Executive Vice Chairman7.25yrsUS$1.24m1.36%
$ 2.8m
Jaime Bartushak
Chief Business Officer5.17yrsUS$809.00k0.041%
$ 84.5k
Myron Czuczman
Executive VP & Chief Medical Officer2.5yrsUS$887.85k0%
$ 0
Gary Talarico
Executive Vice President of Operations6.83yrsno datano data
Ilanit Allen
Vice President of Investor Relations & Corporate Communicationsno datano datano data
Alan Lader
Senior VP & Head of Clinical Operations and Quality Assurance0.92yrno datano data
Dhananjay Wadekar
Senior Vice President of Business Strategy2yrsno datano data
Kelly Creighton
Executive Vice President of Chemistry1.17yrsno datano data

2.5yrs

Average Tenure

67.5yo

Average Age

Experienced Management: CTXR's management team is considered experienced (2.5 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Leonard Mazur
Co-Founder8.33yrsUS$1.19m7.01%
$ 14.4m
Myron Holubiak
Co-Founder & Executive Vice Chairman7.25yrsUS$1.24m1.36%
$ 2.8m
Howard Safir
Lead Independent Director6.83yrsUS$229.89k0%
$ 0
Suren Dutia
Independent Director7.25yrsUS$211.39k0%
$ 0
William Kane
Independent Director6.83yrsUS$212.89k0%
$ 0
Carol Webb
Independent Director6.83yrsUS$205.39k0%
$ 0
Eugene Holuka
Independent Director6.58yrsUS$205.39k0%
$ 0
Issam Raad
Chairman of Scientific Advisory Boardno datano datano data
Mark Rupp
Member of Scientific Advisory Boardno datano datano data
Leonard Mermel
Member of Scientific Advisory Board4.5yrsno datano data
Jesse Selber
Member of Scientific Advisory Boardno datano datano data
George Viola
Member of Scientific Advisory Boardno datano datano data

6.8yrs

Average Tenure

77yo

Average Age

Experienced Board: CTXR's board of directors are considered experienced (6.8 years average tenure).